Microbot Stock Performance


USD 4.51  0.08  1.74%   

The company secures a Beta (Market Risk) of 0.921, which conveys possible diversification benefits within a given portfolio. Let's try to break down what Microbot's beta means in this case. Microbot Medical returns are very sensitive to returns on the market. As the market goes up or down, Microbot Medical is expected to follow. Even though it is essential to pay attention to Microbot Medical price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Microbot Medical exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Microbot Medical has an expected return of -0.1%. Please be advised to verify Microbot Medical value at risk, and the relationship between the jensen alpha and skewness to decide if Microbot Medical performance from the past will be repeated at some point in the near future.
Microbot Performance
0 of 100
Over the last 90 days Microbot Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more

Structure and Payout Changes

Last Split Factor
Dividend Date
Last Split Date

Microbot Price Channel

Begin Period Cash Flow19734000.00
Total Cashflows From Investing Activities3200000.00

Microbot Medical Relative Risk vs. Return Landscape

If you would invest  500.00  in Microbot Medical on September 3, 2022 and sell it today you would lose (49.00)  from holding Microbot Medical or give up 9.8% of portfolio value over 90 days. Microbot Medical is currently does not generate positive expected returns and assumes 3.5691% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Microbot, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Microbot Medical is expected to under-perform the market. In addition to that, the company is 2.37 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.09 per unit of volatility.

Microbot Medical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbot Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Microbot Medical, and traders can use it to determine the average amount a Microbot Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0284

Good Returns
Average Returns
Small Returns
Negative ReturnsMBOT
Estimated Market Risk
  actual daily
 31 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Microbot Medical is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Microbot Medical by adding it to a well-diversified portfolio.

About Microbot Medical Performance

To evaluate Microbot Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Microbot Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Microbot Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Microbot Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Microbot's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-18.7 K-20.2 K
Return on Investment(180.05) (194.27) 
Return on Average Assets(52.56) (56.71) 
Return on Average Equity(58.48) (63.10) 
Return on Invested Capital(2.42) (2.61) 
Return on Sales(27.95) (30.16) 

Things to note about Microbot Medical

Checking the ongoing alerts about Microbot Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Microbot Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Microbot Medical Alerts

Equity Alerts and Improvement Suggestions

Microbot Medical generated a negative expected return over the last 90 days
Microbot Medical has high historical volatility and very poor performance
Net Loss for the year was (11.31 M) with profit before overhead, payroll, taxes, and interest of 0.
Microbot Medical currently holds about 9.29 M in cash with (9.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Microbot Medical has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Microbot Medical Gets US Patent Allowance for Liberty System Interface Design - Marketscreener.com
Additionally, see Correlation Analysis. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for analysis

When running Microbot Medical price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is Microbot Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
35.1 M
Return On Assets
Return On Equity
The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Microbot Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.